Cabot insider plans $11.5M stock sale
CABOT CORP (CBT) is named as the issuer in a Form 144 filing relating to planned sales of its common stock by Sean D. Keohane.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CABOT CORP (CBT) is named as the issuer in a Form 144 filing relating to planned sales of its common stock by Sean D. Keohane. The notice covers up to 134,895 shares of common stock, to be sold following a stock option exercise on August 28, 2026, with sales reported on the NYSE.
Key Figures
Key Terms
Rule 144 regulatory
stock option exercise financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does this Form 144 filing mean for CABOT CORP (CBT)?
What CABOT CORP (CBT) stock sales has Sean D. Keohane made in the last 3 months?
Who is executing the CABOT CORP (CBT) Form 144 sale for Sean D. Keohane?
AI-generated analysis. How Rhea-AI works. Not financial advice.